DJIA 16,262.56 89.32 0.55%
NASDAQ 4,034.16 0.00 0.00%
S&P 500 1,842.98 12.37 0.68%
market minute promo

Celgene

NASDAQ: CELG

139.84 1.78 (1.29%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

CELG $139.84 1.29%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $139.03
Previous Close $138.06
Daily Range $133.70 - $140.95
52-Week Range $110.53 - $174.66
Market Cap $56.8B
P/E Ratio 40.97
Dividend (Yield) $0.00 (0.0%)
Volume 4,214,464
Average Daily Volume 4,445,686
Current FY EPS $6.34

Sector

Healthcare

Industry

Drugs

Celgene (CELG) Description

A biopharmaceutical company primarily engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases. Website: http://www.celgene.com/

News & Commentary Rss Feed

Can Celgene Deliver in 2014?

Celgene (NASDAQ: CELG) had a strong 2013, but 2014 is not quite going to plan. Can it turn things around?

Stock Market News for April 14, 2014 - Market News

Celgene Growth Unappreciated In Recent Sell-Off

3 Stocks Reiterated As A Buy: CAT, CELG, CMCSA

Stock Market News for April 11, 2014 - Market News

3 Drugs Stocks Driving The Industry Higher

Today's Market: Playing The Biotech Bloodbath

Three Biotech Companies That Look To Be Good Buys After A Pullback

Tech stock rout continues in Asia

Asia tech stocks fall into the red

Is the robust IPO market affecting the broader indices?

The Momentum Tell and the Yellen Timeline

See More CELG News...

CELG's Top Competitors

CELG $139.84 (1.29%)
Current stock: CELG
GILD $68.17 (2.07%)
Current stock: GILD
BIIB $285.49 (2.14%)
Current stock: BIIB
$0.00 (0.00%)
Current stock: